Success Stories: I-140 NIW Approved for a Researcher from China in Tumor Immunology due to NAILG’s Arbitration

On July 13^th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher in the field of Immunology (Approval Notice).

General Field: Immunology

Position at the Time of Case Filing: Researcher

Country of Origin: China

Approval Notice Date: July 13^th, 2021

Processing Time: 11 months, 18 days

Case Summary:

Armed with a Postdoctoral Degree, a researcher from China approached NAILG (North America Immigration Law Group) to help her in adjudicating with the USCIS on her behalf. Her proposed endeavor to investigate the underlying epigenetic mechanisms driving autoimmune disease and cancer proliferation in order to identify viable new targets and compounds for drug development to treat these conditions was not only thoroughly researched but also had the potential to transform the US healthcare system. This prompted us to look at her academic and past professional records before countersigning the retainer document.

Her excellent academic and professional record helped us tailor the case to her strengths. We tried to showcase her achievements by putting together a list of publications, citations, and reviews, demonstrating her constant engagement and impact upon other researchers in her field. Her 8 peer-reviewed publications (2 of them first-authored) have been cited a total of 682 times according to Google Scholar, thereby illustrating that these publications are widely recognized and relied upon in the field of immunology. She has thus authored 1 paper that ranks among the top 0.01%%, 1 paper that ranks among the top 0.1%, 1 paper that ranks among the top 1%, 2 papers that rank among the top 10%, and 1 paper that ranks among the top 20% most-cited articles across the entire field for Immunology for their respective years of publication.

Another thing that we take note of at NAILG is the letters of recommendation obtained from dependent and independent experts in the field. With her case some of the recommenders had the following to say about the import of her work to the US and its health care system:

“In the United States, colorectal cancer is the second leading cause of cancer death among men and women combined. In many cases, colorectal cancer is preceded by common inﬂammatory gastrointestinal diseases like ulcerative colitis and Crohn’s disease. Both of these conditions are characterized as inﬂammatory bowel diseases, so [the client’s] investigation to understand how to more effectively mitigate inﬂammation is substantially important to the United States.”

“[The Client’s] evaluation of the mechanisms that incite inﬂammation, therefore, contributes to her efforts to design treatments for autoimmune diseases and colorectal cancer. In particular, the prevalence of autoimmune diseases nationwide makes [the Client’s]research of specific interest to the United States.”

We would like to thank our client for her confidence in our experience with how USCIS adjudicates in matters of National Interest Waiver (NIW) petition. Thanks to our legal strategies earned over several years of some 25,000+ successful approvals, we were victorious in her case too. We wish her the very best and we are certain that her research will transform the field of immunology.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.